文献速递认知障碍与痴呆

阿尔茨海默病的正电子发射断层显像引导磁共振波谱研究

Positron emission tomography-guided magnetic resonance spectroscopy in Alzheimer disease.
PubMed 文献 · Ann Neurol · 2018-04-10

研究在很可能阿尔茨海默病、轻度认知障碍和健康对照中开展正电子发射断层显像(PET)引导的磁共振波谱(MRS),将体素置于淀粉样蛋白(Aβ+)和葡萄糖代谢减低(FDG)异常最明显区域。Aβ+区肌醇/肌酸比值升高、总N-乙酰基/肌酸比值降低,代谢减低区仅总N-乙酰基/肌酸比值降低;肌醇/肌酸比值仅与11C-PiB标准化摄取值比相关,总N-乙酰基/肌酸比值与两者均相关。

要点

  • Aβ+区mI/Cr升高(p=0.02)、tNA/Cr降低(p=0.02)
  • 代谢减低区仅tNA/Cr降低(p=0.003)
  • tNA/Cr从健康对照到轻度认知障碍到阿尔茨海默病逐步下降(p=0.001,p=0.04)

核心结论

  • mI/Cr与Aβ在时间和空间上存在显著关联,可能被视为疾病状态生物标志物。
  • tNA是早期神经退行性改变的指标,可能作为疾病分期生物标志物及治疗反应的有价值替代标志物。

研究设计与样本

  • 在很可能阿尔茨海默病、轻度认知障碍和健康对照中开展PET引导的MRS。
  • 所有参与者均接受11C-匹兹堡化合物B(11C-PiB)和18F-氟脱氧葡萄糖(18F-FDG)PET,随后进行3T MRS。
  • PET图像采用视觉评估和标准化摄取值比(SUVR)两种方式评估。
  • MRS体素置于PET扫描中淀粉样蛋白(Aβ+)和FDG(代谢减低)异常最明显区域,并在对照中选择相应正常区域。

主要发现

  • Aβ+区mI/Cr显著升高(p=0.02),tNA/Cr显著降低(p=0.02)。
  • 代谢减低区仅tNA/Cr降低(p=0.003)。
  • 校正性别、年龄和教育后,mI/Cr仅与11C-PiB SUVR相关(p<0.0001)。
  • tNA/Cr与PiB(p=0.0003)和18F-FDG SUVR(p=0.006)均相关。
  • mI/Cr在轻度认知障碍与阿尔茨海默病之间无显著差异(p=0.28),tNA/Cr从健康对照到轻度认知障碍到阿尔茨海默病显著下降(p=0.001,p=0.04)。

关键数值与推荐

  • 比较指标为总N-乙酰基(tNA)、肌醇(mI)、胆碱、谷氨酸+谷氨酰胺与肌酸(Cr)的比值。
  • Aβ+区mI/Cr较对照升高(p=0.02),tNA/Cr较对照降低(p=0.02)。
  • 代谢减低区tNA/Cr降低(p=0.003)。
  • mI/Cr与11C-PiB SUVR相关(p<0.0001);tNA/Cr与PiB SUVR相关(p=0.0003)、与18F-FDG SUVR相关(p=0.006)。
  • mI/Cr在轻度认知障碍与阿尔茨海默病间无显著差异(p=0.28);tNA/Cr从健康对照到轻度认知障碍(p=0.001)、从轻度认知障碍到阿尔茨海默病(p=0.04)显著下降。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether the level of metabolites in magnetic resonance spectroscopy (MRS) is a representative marker of underlying pathological changes identified in positron emission tomographic (PET) images in Alzheimer disease (AD). METHODS: We performed PET-guided MRS in cases of probable AD, mild cognitive impairment (MCI), and healthy controls (HC). All participants were imaged by 11 C-Pittsburgh compound B (11 C-PiB) and 18 F-fluorodeoxyglucose (18 F-FDG) PET followed by 3T MRS. PET images were assessed both visually and using standardized uptake value ratios (SUVRs). MRS voxels were placed in regions with maximum abnormality on amyloid (Aβ+) and FDG (hypometabolic) areas on PET scans. Corresponding normal areas were selected in controls. The ratios of total N-acetyl (tNA) group, myoinositol (mI), choline, and glutamate + glutamine over creatine (Cr) were compared between these regions. RESULTS: Aβ + regions had significantly higher (p = 0.02) mI/Cr and lower tNA/Cr (p = 0.02), whereas in hypometabolic areas only tNA/Cr was reduced (p = 0.003). Multiple regression analysis adjusting for sex, age, and education showed mI/Cr was only associated with 11 C-PiB SUVR (p < 0.0001). tNA/Cr, however, was associated with both PiB (p = 0.0003) and 18 F-FDG SUVR (p = 0.006). The level of mI/Cr was not significantly different between MCI and AD (p = 0.28), but tNA/Cr showed significant decline from HC to MCI to AD (p = 0.001, p = 0.04). INTERPRETATION: mI/Cr has significant temporal and spatial associations with Aβ and could potentially be considered as a disease state biomarker. tNA is an indicator of early neurodegenerative changes and might have a role as disease stage biomarker and also as a valuable surrogate marker for treatment response. Ann Neurol 2018;83:771-778.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Sheikh-Bahaei N, Sajjadi SA, Manavaki R, et al. Positron emission tomography-guided magnetic resonance spectroscopy in Alzheimer disease. Ann Neurol. 2018. PMID: 29518282. doi:10.1002/ana.25202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。